BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 28292441)

  • 61. [Identification of speckle type BTB/POZ protein mutation regulated key metabolic pathways by cell based proteomics and metabolomics].
    Yan M; Liu J; Xia T; Xu G; Piao H
    Se Pu; 2019 Aug; 37(8):887-896. PubMed ID: 31642260
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Role of mTOR signaling pathway proteins and proteins influencing mTOR pathway in resistance to radiotherapy in prostate cancer.
    Benderli Cihan Y
    J BUON; 2018; 23(6):1931-1932. PubMed ID: 30610829
    [No Abstract]   [Full Text] [Related]  

  • 63. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells.
    Lin HK; Hu YC; Lee DK; Chang C
    Mol Endocrinol; 2004 Oct; 18(10):2409-23. PubMed ID: 15205473
    [TBL] [Abstract][Full Text] [Related]  

  • 64. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.
    Majumder PK; Febbo PG; Bikoff R; Berger R; Xue Q; McMahon LM; Manola J; Brugarolas J; McDonnell TJ; Golub TR; Loda M; Lane HA; Sellers WR
    Nat Med; 2004 Jun; 10(6):594-601. PubMed ID: 15156201
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The diverse roles of SPOP in prostate cancer and kidney cancer.
    Wang Z; Song Y; Ye M; Dai X; Zhu X; Wei W
    Nat Rev Urol; 2020 Jun; 17(6):339-350. PubMed ID: 32355326
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A picture with more details is painted for prostate cancer.
    Liu W; Feng J; Xu J
    Asian J Androl; 2012 Nov; 14(6):799-800. PubMed ID: 22842705
    [No Abstract]   [Full Text] [Related]  

  • 67. Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer.
    García-Flores M; Casanova-Salas I; Rubio-Briones J; Calatrava A; Domínguez-Escrig J; Rubio L; Ramírez-Backhaus M; Fernández-Serra A; García-Casado Z; López-Guerrero JA
    Eur J Cancer; 2014 Nov; 50(17):2994-3002. PubMed ID: 25204806
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prostate cancer heterogeneity: Discovering novel molecular targets for therapy.
    Ciccarese C; Massari F; Iacovelli R; Fiorentino M; Montironi R; Di Nunno V; Giunchi F; Brunelli M; Tortora G
    Cancer Treat Rev; 2017 Mar; 54():68-73. PubMed ID: 28231559
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer.
    Lehrer S; Rheinstein PH
    Cancer Genomics Proteomics; 2020; 17(3):271-275. PubMed ID: 32345668
    [TBL] [Abstract][Full Text] [Related]  

  • 70. TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression.
    Fong KW; Zhao JC; Song B; Zheng B; Yu J
    Nat Commun; 2018 Nov; 9(1):5007. PubMed ID: 30479348
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
    Barbieri CE; Baca SC; Lawrence MS; Demichelis F; Blattner M; Theurillat JP; White TA; Stojanov P; Van Allen E; Stransky N; Nickerson E; Chae SS; Boysen G; Auclair D; Onofrio RC; Park K; Kitabayashi N; MacDonald TY; Sheikh K; Vuong T; Guiducci C; Cibulskis K; Sivachenko A; Carter SL; Saksena G; Voet D; Hussain WM; Ramos AH; Winckler W; Redman MC; Ardlie K; Tewari AK; Mosquera JM; Rupp N; Wild PJ; Moch H; Morrissey C; Nelson PS; Kantoff PW; Gabriel SB; Golub TR; Meyerson M; Lander ES; Getz G; Rubin MA; Garraway LA
    Nat Genet; 2012 May; 44(6):685-9. PubMed ID: 22610119
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
    Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
    Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
    [TBL] [Abstract][Full Text] [Related]  

  • 73. SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.
    Ma J; Chang K; Peng J; Shi Q; Gan H; Gao K; Feng K; Xu F; Zhang H; Dai B; Zhu Y; Shi G; Shen Y; Zhu Y; Qin X; Li Y; Zhang P; Ye D; Wang C
    J Exp Clin Cancer Res; 2018 Jul; 37(1):145. PubMed ID: 29996942
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Genomics of Prostate Cancer: emerging understanding with technologic advances.
    Rubin MA; Demichelis F
    Mod Pathol; 2018 Jan; 31(S1):S1-11. PubMed ID: 29297493
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer.
    Yan Y; Ma J; Wang D; Lin D; Pang X; Wang S; Zhao Y; Shi L; Xue H; Pan Y; Zhang J; Wahlestedt C; Giles FJ; Chen Y; Gleave ME; Collins CC; Ye D; Wang Y; Huang H
    EMBO Mol Med; 2019 Nov; 11(11):e10659. PubMed ID: 31559706
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.
    Narayanan NK; Nargi D; Randolph C; Narayanan BA
    Int J Cancer; 2009 Jul; 125(1):1-8. PubMed ID: 19326431
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer.
    Theurillat JP; Udeshi ND; Errington WJ; Svinkina T; Baca SC; Pop M; Wild PJ; Blattner M; Groner AC; Rubin MA; Moch H; Prive GG; Carr SA; Garraway LA
    Science; 2014 Oct; 346(6205):85-89. PubMed ID: 25278611
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Molecular Taxonomy of Primary Prostate Cancer.
    Cancer Genome Atlas Research Network
    Cell; 2015 Nov; 163(4):1011-25. PubMed ID: 26544944
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Mutational and Transcriptional Landscapes of Speckle-Type POZ Protein (SPOP) and Androgen Receptor (AR) in a Single-Center pT3 Prostatectomy Cohort.
    Eryilmaz IE; Vuruskan BA; Kaygisiz O; Cecener G; Egeli U; Vuruskan H
    J Environ Pathol Toxicol Oncol; 2024; 43(1):15-29. PubMed ID: 37824367
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TGF-β signaling regulates
    Jiao C; Meng T; Zhou C; Wang X; Wang P; Lu M; Tan X; Wei Q; Ge X; Jin J
    Aging (Albany NY); 2020 May; 12(9):7747-7760. PubMed ID: 32364525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.